Fresenius Kabi

mAbxience is a biotechnology company founded in 2009, focused on the research, development, and manufacture of biologic products, particularly biosimilar drugs. With operations in Spain and Argentina, mAbxience has established a strong international presence in major pharmaceutical markets. The company is dedicated to the sustainability of healthcare systems globally and aims to enhance treatment options for various diseases through the development and commercialization of monoclonal antibodies. mAbxience currently markets two fully developed biosimilars and has four additional products in the developmental phase, all while maintaining a commitment to high-quality standards that comply with regulatory and technical requirements in the countries where it operates.

Ivenix, Inc. is a medical technology company based in North Andover, Massachusetts, specializing in the development of advanced intravenous (IV) infusion systems. Founded in 2001 and originally known as Fluidnet Corporation, Ivenix offers a next-generation infusion management platform that utilizes pneumatic technology to enhance the accuracy of fluid delivery. This innovative system is designed to measure and control flow regardless of factors such as bag height, backpressure, patient movement, and fluid viscosity. Additionally, the platform manages patient infusion data and integrates seamlessly with clinical information systems, ensuring precise and continuous infusion delivery in hospital settings. Ivenix aims to revolutionize infusion therapy worldwide by combining state-of-the-art information technology with user-friendly design, thereby improving patient care and safety.

Fenwal is a global leader specializing in the development and manufacturing of blood transfusion systems. Their products collect, separate, process, filter, store, and administer whole blood and its components for therapeutic use, supporting medical professionals worldwide in treating various conditions such as cancer, kidney failure, hemophilia, immune deficiencies, and infectious diseases. Fenwal serves blood centers, hospital blood banks, and plasma collection centers globally.

Ribbon is engages in the manufacture and sale of bulk active ingredients for the pharmaceutical industry. It offers betalactam antibiotics with a range of specialized products, such as semi-synthetic penicillins and cephalosporin; and B-Lactamase inhibitor.

Laboratorio Sanderson is a pharmaceutical company that specializes in the manufacture, commercialization, and distribution of injectable medications and products. The company serves both public and private healthcare sectors, providing a range of large-volume parenteral (LVP) solutions, including electrolytes, dextrose, sodium bicarbonate, and products for peritoneal dialysis. Additionally, Laboratorio Sanderson offers small-volume parenteral (SVP) solutions, which encompass a variety of medications such as antibiotics, analgesics, narcotic-analgesics, hormones, and various other therapeutic agents. Their products are designed to meet the needs of hospitals, clinics, medical centers, dialysis centers, and pharmacies, ensuring accessibility to essential medications in both national and international markets.

Labesfal - Laboratórios Almiro is manufactures and markets generic and intravenously administered drugs for therapeutic areas. The company’s products are used in the treatment of anti-infective, cardiovascular, analgesic, antipyretic, gastroenterologic, anti-histamine, and central nerves system related diseases.